BioCardia, Inc.
Hedge Funds Holdings
Last updated:
BioCardia, Inc.‘s stocks are currently a part of 14 hedge funds’ portfolios, which represents 4.05% of the total amount of its stocks outstanding. This makes up a total of 1.03M shares of BioCardia, Inc.. Compared to the previous quarter, the number fell by -55.58% or -1.29M shares fewer. As for the holding position changes, 21.43% (3) of current hedge fund investors increased the number of shares held, 28.57% (4) of current holders sold a part of the shares held, and 14.29% (2) closed the holdings completely. 1 hedge funds are new holders of BioCardia, Inc. stock in Q1 2023, it is 7.14% of total holders.
Hedge funds holding BioCardia (Q2 2018 – Q1 2023)
| Q2 2018 | 1 |
|---|---|
| Q3 2018 | 1 |
| Q4 2018 | 2 |
| Q1 2019 | 2 |
| Q2 2019 | 2 |
| Q3 2019 | 8 |
| Q4 2019 | 7 |
| Q1 2020 | 5 |
| Q2 2020 | 10 |
| Q3 2020 | 6 |
| Q4 2020 | 14 |
| Q1 2021 | 18 |
| Q2 2021 | 19 |
| Q3 2021 | 21 |
| Q4 2021 | 22 |
| Q1 2022 | 23 |
| Q2 2022 | 24 |
| Q3 2022 | 22 |
| Q4 2022 | 25 |
| Q1 2023 | 14 |
Hedge funds changes in BioCardia positions (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 | 0 | 1 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 0 | 0 | 0 | 0 | 1 |
| Q4 2018 | 1 | 0 | 0 | 0 | 1 |
| Q1 2019 | 0 | 0 | 0 | 0 | 2 |
| Q2 2019 | 1 | 1 | 0 | 1 | -1 |
| Q3 2019 | 8 | 0 | 0 | 2 | -2 |
| Q4 2019 | 1 | 2 | 2 | 2 | 0 |
| Q1 2020 | 1 | 0 | 2 | 1 | 1 |
| Q2 2020 | 6 | 0 | 3 | 1 | 0 |
| Q3 2020 | 0 | 2 | 0 | 4 | 0 |
| Q4 2020 | 8 | 3 | 1 | 0 | 2 |
| Q1 2021 | 5 | 7 | 3 | 1 | 2 |
| Q2 2021 | 4 | 5 | 5 | 3 | 2 |
| Q3 2021 | 6 | 2 | 5 | 4 | 4 |
| Q4 2021 | 4 | 6 | 2 | 3 | 7 |
| Q1 2022 | 5 | 4 | 5 | 4 | 5 |
| Q2 2022 | 3 | 4 | 5 | 2 | 10 |
| Q3 2022 | 2 | 6 | 3 | 4 | 7 |
| Q4 2022 | 4 | 6 | 6 | 1 | 8 |
| Q1 2023 | 1 | 3 | 4 | 2 | 4 |
Hedge funds changes in BioCardia stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 540,000 |
| Q2 2021 | 83,000 | 56,000 |
| Q3 2021 | 228,000 | 69,000 |
| Q4 2021 | 149,000 | 191,000 |
| Q1 2022 | 87,000 | 195,000 |
| Q2 2022 | 78,000 | 29,000 |
| Q3 2022 | 571,000 | 179,000 |
| Q4 2022 | 596,597 | 296,559 |
| Q1 2023 | 68,000 | 61,000 |